Aging, Premature, Congenital Heart Disease, White Matter Hyperintensities
Conditions
Brief summary
The study aims at investigating the role of cyanotic congenital heart disease (cCHD) on brain aging. The investigators assume that due to congenital and acquired cardiovascular abnormalities, cCHD patients could show radiologic (and clinical) signs of precocious brain aging and eventual cognitive decline.
Detailed description
White matter hyperintensities burden will be quantified through a semi-autamated software (ITK-SNAP)
Interventions
OTHERBrain MRI
Acquisition of 3D T1-weighted, 3D FLAIR and GRE brain MRI scans
1. Mini Mental State Examination (MMSE), Measso et al. (1993); 2. Frontal Assessment Battery (FAB), Appollonio et al. (2005); 3. Symbol Digit Test, Amodio et al. (2002); 4. Digit Cancellation Test, Della Sala et al. (1992); 5. Trial Making Test (TMT A-B), Giovagnoli et al. (1996); 6. Weigl's Sorting Test, Laicona et al. (2000) and Inzaghi (2010); 7. Digit Span, Orsini et al (1987); 8. Corsi block-tapping test, Orsini et al. (1987); 9. Babcock story recall test, Carlesimo et al. (2002); 10. Phonemic verbal fluency in MDB, Caltagirone and Carlesimo (2010); 11. Semantic verbal fluency, Novelli (1986); 12. Imitating gestures, De Renzi et al. (1980); 13. Coloured Progressive Matrices (CPM47), Measso et al. (1993).
Sponsors
IRCCS Policlinico S. Donato
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* for the patient group, being an adult subject affected with cyanotic congenital heart disease, whether surgically corrected or not. * for the control group, being an healthy subject.
Exclusion criteria
* any contraindication to magnetic resonance imaging; * any pathological condition and/or symptomp that could alter the white matter hyperintensities burden, among which: * inflammatory, infectious, demyelinating or dysmyelinating diseases of the CNS; * ischemic, haemorrhagic or traumatic brain events and eventual gliotic and malacic or lacunar sequelae; * genetic diseases (whether mendelian or mitochondrial) of the CNS; * cerebral amyloid angiopathy; * CADASIL; * cerebral arteriovenous malformations; * primary or metastatic brain neoplasms which cause neurological symptoms and/or brain parenchymal sequelae from surgical excision; * patent oval foramen; * being pregnant; * migraine with aura (Bashir, Lipton, Ashina, & Ashina, 2013).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| White matter hyperintensities volume expressed in mm^3 | 3 years | Semi-automated quantification performed through ITK-SNAP |
Countries
Italy
Outcome results
None listed